Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Clinical trial NCT02649751 · TERMINATED
Trial details
- NCT number
- NCT02649751
- Sponsor
- University Hospital, Brest
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-22
- Primary completion
- 2018-07-26
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.